Tempest Therapeutics, Inc. (TPST) › Operating IncomeTempest Therapeutics, Inc. (TPST) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2012: -$13.53M2013: -$29.13M2014: -$47.93M2015: -$72.00M2016: -$81.01M2017: -$84.33M2018: -$26.87M2019: -$45.40M2020: -$19.30M2021: -$26.99M2022: -$34.64M2023: -$29.16M2024: -$42.03M2025: -$26.57M-$26.57M2012Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$26.57M+36.8%2024-$42.03M-44.1%2023-$29.16M+15.8%2022-$34.64M-28.4%2021-$26.99M-39.8%2020-$19.30M+57.5%2019-$45.40M-68.9%2018-$26.87M+68.1%2017-$84.33M-4.1%2016-$81.01M-12.5%2015-$72.00M-50.2%2014-$47.93M-64.5%2013-$29.13M-115.3%2012-$13.53M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share